Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 2
2021 11
2022 9
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean loss study group[Corporate Author] (8 results)?
Convalescent plasma treatment for SARS-CoV-2 infected high-risk patients: a matched pair analysis to the LEOSS cohort.
Freise NF, Gliga S, Fischer J, Lübke N, Lutterbeck M, Schöler M, Bölke E, Orth HM, Feldt T, Roemmele C, Wilke D, Schneider J, Wille K, Hohmann C, Strauss R, Hower M, Ruf A, Schubert J, Isberner N, Stecher M, Pilgram L, Vehreschild JJ; LEOSS Study Group; Hanses F, Luedde T, Jensen B. Freise NF, et al. Sci Rep. 2022 Nov 9;12(1):19035. doi: 10.1038/s41598-022-23200-1. Sci Rep. 2022. PMID: 36351986 Free PMC article.
Disease severity in hospitalized COVID-19 patients: comparing routine surveillance with cohort data from the LEOSS study in 2020 in Germany.
Koppe U, Schilling J, Stecher M, Rüthrich MM, Marquis A, Diercke M, Haselberger M, Koll CEM, Niebank M, Ruehe B, Borgmann S, Grabenhenrich L, Hellwig K, Pilgram L, Spinner CD, Paerisch T; LEOSS study group. Koppe U, et al. BMC Infect Dis. 2023 Feb 10;23(1):89. doi: 10.1186/s12879-023-08035-z. BMC Infect Dis. 2023. PMID: 36765274 Free PMC article.
Gastrointestinal bleeding and endoscopic findings in critically and non-critically ill patients with corona virus disease 2019 (COVID-19): Results from Lean European Open Survey on SARS-CoV-2 (LEOSS) and COKA registries.
Zellmer S, Hanses F, Muzalyova A, Classen J, Braun G, Piepel C, Erber J, Pilgram L, Walter L, Göpel S, Wille K, Hower M, Rüthrich MM, Rupp J, Degenhardt C, Voigt I, Borgmann S, Stecher M, Jakob C, Dhillon C, Messmann H, Ebigbo A, Römmele C; LEOSS study group. Zellmer S, et al. United European Gastroenterol J. 2021 Nov;9(9):1081-1090. doi: 10.1002/ueg2.12165. Epub 2021 Oct 15. United European Gastroenterol J. 2021. PMID: 34655180 Free PMC article.
Hospitalized patients dying with SARS-CoV-2 infection-An analysis of patient characteristics and management in ICU and general ward of the LEOSS registry.
Raichle C, Borgmann S, Bausewein C, Rieg S, Jakob CEM, Simon ST, Tometten L, Vehreschild JJ, Leisse C, Erber J, Stecher M, Pauli B, Rüthrich MM, Pilgram L, Hanses F, Isberner N, Hower M, Degenhardt C, Hertenstein B, Vehreschild MJGT, Römmele C, Jung N; LEOSS Study Group. Raichle C, et al. PLoS One. 2022 Jul 29;17(7):e0271822. doi: 10.1371/journal.pone.0271822. eCollection 2022. PLoS One. 2022. PMID: 35905129 Free PMC article.
Outcomes of SARS-CoV-2 Infections in Patients with Neurodegenerative Diseases in the LEOSS Cohort.
Huber MK, Raichle C, Lingor P, Synofzik M, Borgmann S, Erber J, Tometten L, Rimili W, Dolff S, Wille K, Knauss S, Piepel C, Lanznaster J, Rieg S, Prasser F, Pilgram L, Spottke A, Klockgether T, Klein C, Hopfner F, Höglinger GU; LEOSS Study Group. Huber MK, et al. Mov Disord. 2021 Apr;36(4):791-793. doi: 10.1002/mds.28554. Epub 2021 Feb 27. Mov Disord. 2021. PMID: 33638915 Free PMC article. No abstract available.
Prediction of COVID-19 deterioration in high-risk patients at diagnosis: an early warning score for advanced COVID-19 developed by machine learning.
Jakob CEM, Mahajan UM, Oswald M, Stecher M, Schons M, Mayerle J, Rieg S, Pletz M, Merle U, Wille K, Borgmann S, Spinner CD, Dolff S, Scherer C, Pilgram L, Rüthrich M, Hanses F, Hower M, Strauß R, Massberg S, Er AG, Jung N, Vehreschild JJ, Stubbe H, Tometten L, König R; LEOSS Study group. Jakob CEM, et al. Infection. 2022 Apr;50(2):359-370. doi: 10.1007/s15010-021-01656-z. Epub 2021 Jul 19. Infection. 2022. PMID: 34279815 Free PMC article.
Neurological symptoms and complications in predominantly hospitalized COVID-19 patients: Results of the European multinational Lean European Open Survey on SARS-Infected Patients (LEOSS).
Kleineberg NN, Knauss S, Gülke E, Pinnschmidt HO, Jakob CEM, Lingor P, Hellwig K, Berthele A, Höglinger G, Fink GR, Endres M, Gerloff C, Klein C, Stecher M, Classen AY, Rieg S, Borgmann S, Hanses F, Rüthrich MM, Hower M, Tometten L, Haselberger M, Piepel C, Merle U, Dolff S, Degenhardt C, Jensen BO, Vehreschild MJGT, Erber J, Franke C, Warnke C; LEOSS Study Group. Kleineberg NN, et al. Eur J Neurol. 2021 Dec;28(12):3925-3937. doi: 10.1111/ene.15072. Epub 2021 Sep 3. Eur J Neurol. 2021. PMID: 34411383 Free PMC article.
COVID-19 in cancer patients: clinical characteristics and outcome-an analysis of the LEOSS registry.
Rüthrich MM, Giessen-Jung C, Borgmann S, Classen AY, Dolff S, Grüner B, Hanses F, Isberner N, Köhler P, Lanznaster J, Merle U, Nadalin S, Piepel C, Schneider J, Schons M, Strauss R, Tometten L, Vehreschild JJ, von Lilienfeld-Toal M, Beutel G, Wille K; LEOSS Study Group. Rüthrich MM, et al. Ann Hematol. 2021 Feb;100(2):383-393. doi: 10.1007/s00277-020-04328-4. Epub 2020 Nov 7. Ann Hematol. 2021. PMID: 33159569 Free PMC article.
Machine Learning Based Prediction of COVID-19 Mortality Suggests Repositioning of Anticancer Drug for Treating Severe Cases.
Linden T, Hanses F, Domingo-Fernández D, DeLong LN, Kodamullil AT, Schneider J, Vehreschild MJGT, Lanznaster J, Ruethrich MM, Borgmann S, Hower M, Wille K, Feldt T, Rieg S, Hertenstein B, Wyen C, Roemmele C, Vehreschild JJ, Jakob CEM, Stecher M, Kuzikov M, Zaliani A, Fröhlich H; LEOSS study group. Linden T, et al. Artif Intell Life Sci. 2021 Dec;1:100020. doi: 10.1016/j.ailsci.2021.100020. Epub 2021 Dec 17. Artif Intell Life Sci. 2021. PMID: 34988543 Free PMC article.
COVID-19 mortality in cirrhosis is determined by cirrhosis-associated comorbidities and extrahepatic organ failure: Results from the multinational LEOSS registry.
Brozat JF, Hanses F, Haelberger M, Stecher M, Dreher M, Tometten L, Ruethrich MM, Vehreschild JJ, Trautwein C, Borgmann S, Vehreschild MJGT, Jakob CEM, Stallmach A, Wille K, Hellwig K, Isberner N, Reuken PA, Geisler F, Nattermann J, Bruns T; LEOSS study group. Brozat JF, et al. United European Gastroenterol J. 2022 May;10(4):409-424. doi: 10.1002/ueg2.12232. Epub 2022 Apr 28. United European Gastroenterol J. 2022. PMID: 35482663 Free PMC article.
22 results